ctrl K

Watchlist Price Alert

Actuate Therapeutics Inc (ACTU)

NASDAQ: ACTU · Real-Time Price · USD

9.14

-0.75 (-7.58%)

At close: May 06, 2025, 3:59 PM

Actuate Therapeutics Inc Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-25.16M	-24.97M	-20.21M
Interest Income	222.29K	352.67K	27.03K
Pretax Income	-27.28M	-24.74M	-20.16M
Net Income	-27.29M	-24.74M	-20.16M
Selling & General & Admin	6.48M	3.27M	3.82M
Research & Development	18.68M	21.71M	16.39M
Other Expenses	n/a	n/a	n/a
Operating Expenses	25.16M	24.97M	20.21M
Interest Expense	-18.72K	43.64K	16.2K
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	n/a	24.97M	20.21M
Income Tax Expense	800.00	n/a	n/a
Shares Outstanding (Basic)	8.37M	15.03M	15.03M
Shares Outstanding (Diluted)	8.37M	15.03M	15.03M
EPS (Basic)	-3.26	-1.65	-1.34
EPS (Diluted)	-3.26	-1.65	-1.34
EBITDA	-25.16M	-24.7M	-20.14M
EBIT	-27.3M	-24.7M	-20.14M
Depreciation & Amortization	2.14M	272.85K	63.61K